1. Home
  2. AMP vs ZTS Comparison

AMP vs ZTS Comparison

Compare AMP & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameriprise Financial Inc.

AMP

Ameriprise Financial Inc.

HOLD

Current Price

$463.86

Market Cap

48.1B

Sector

Finance

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$121.41

Market Cap

54.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMP
ZTS
Founded
1894
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.1B
54.8B
IPO Year
2008
2012

Fundamental Metrics

Financial Performance
Metric
AMP
ZTS
Price
$463.86
$121.41
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
$560.20
$156.20
AVG Volume (30 Days)
689.1K
3.9M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
1.35%
1.73%
EPS Growth
9.77
10.05
EPS
36.28
6.02
Revenue
$18,911,000,000.00
$9,467,000,000.00
Revenue This Year
$1.71
$5.69
Revenue Next Year
$4.38
$4.81
P/E Ratio
$13.02
$20.32
Revenue Growth
5.49
2.28
52 Week Low
$396.14
$115.25
52 Week High
$550.18
$177.00

Technical Indicators

Market Signals
Indicator
AMP
ZTS
Relative Strength Index (RSI) 41.81 38.09
Support Level $463.00 $117.42
Resistance Level $515.17 $130.52
Average True Range (ATR) 12.64 3.28
MACD -0.61 -0.79
Stochastic Oscillator 38.87 22.33

Price Performance

Historical Comparison
AMP
ZTS

About AMP Ameriprise Financial Inc.

Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: